White Blood Cell Profile among Different Clinical Stages of COVID-19 Patients


  •   Khushbun Nahar Layla

  •   Shahanara Yeasmin

  •   Sharif Ahmed Khan

  •   Khyrun Nahar Shaila

  •   Afrina Binte Azad

  •   Rahnuma Ahmad

  •   Samina Rahman


Coronavirus is affecting millions of people world-wide. Coronavirus disease 2019 (COVID-19) is declared a pandemic by WHO. Severe acute respiratory syndrome corona virus 2(SARS-CoV-2) is the causative agent. The clinical presentations of SARS-CoV-2 infection range from febrile illness to pneumonia, ARDS and multi organ failures. Increasing scientific evidences have shown that abnormalities in routine laboratory test, particularly haematological parameters influence the outcome of the disease. Here variations in WBC profile in several clinical forms of COVID-19 patients are observed, The clinical course of the disease may change with haematological parameters such as lower total count of WBC, lymphocyte, higher neutrophil count, eosinophil count etc. By investigating haematological parameters of different clinical stage of RT-PCR positive 100 COVID-19 patients, statistically significant association (p value 0.001) of lymphocyte count with disease severity was found. It is also found that higher level of total count WBC, neutrophil count in severe group in comparison to mild and moderate groups but failed to reach any statistical significance. Moreover total count WBC and neutrophil count showed positive correlations but lymphocyte count, eosinophil count and monocyte count showed negative correlation with severity of disease. So, complete analysis of the haematological parameters will be very much helpful for early detection of complications & better control of the disease.

Keywords: COVID-19, SARS-C0-V-2, RT-PCR, WBC


N. Zhu , D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu and P. Niu, “A novel coronavirus from patients with pneumonia in China, 2019,” New England Journal of Medicine 382Z: 727-733, 2020.

F. Jiang, L. Deng, L. Zhang, Y. Cai, C. W. Cheung and Z. Xia, “Review of the clinical characteristics of coronavirus disease 2019 (COVID-19),” Journal of General Internal Medicine 35(5): 1545-1549, 2020.

N. C. Peeri, N. Shrestha, M. S. Rahman, R. Zaki, Z. Tan, S. Bibi, M. Baghbanzadeh, N. Aghamohammadi, W. Zhang and U. Haque, “The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?” International Journal of Epidemiology 49(3): 717-726, 2020.

X. Yuan, W. Huang, B. Ye, C. Chen, R. Huang, F. Wu, Q. Wei, W. Zhang and J. Hu, “Changes of hematological and immunological parameters in COVID-19 patients,” International Journal of Hematology 112(4): 553-559, 2020.

M. N. Bhuiyan, S. Giti, M. S. Hossen, M. M. Rahman, M. N. Zannat and S. Chokroborty, “Haematologic Profile Abnormalities and Coagulopathy Associated with Covid-19: A Prospective Study of 100 Patients,” Journal of Bangladesh College of Physicians and Surgeons, 3: 61-66, 2020.

S. Wan, Y. I. Xiang, W. Fang, Y. Zheng, B. Li, Y. Hu, C. Lang, D. Huang, Q. Sun, Y. Xiong and X. Huang, “Clinical features and treatment of COVID‐19 patients in northeast Chongqing,” Journal of Medical Virology 92(7): 797-806, 2020.

C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu and Z. Cheng, “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” The Lancet 395(10223): 497-506, 2020.

P. Xu, Q. Zhou and J. Xu, “Mechanism of thrombocytopenia in COVID-19 patients,” Annals of Hematology 99(6): 1205-1208, 2020.

M. Cascella, M. Rajnik, A. Aleem, S. Dulebohn and R. Di Napoli, “Features, evaluation, and treatment of coronavirus (COVID-19),” SatPearls 52(71): 1-7, 2021.

A. Amgalan and M. Othman, “Exploring possible mechanisms for COVID‐19 induced thrombocytopenia: Unanswered questions,” Journal of Thrombosis and Haemostasis 18(6): 1514-1516, 2020.

G. Lippi and M. Plebani, “Laboratory abnormalities in patients with COVID-2019 infection,” Clinical Chemistry and Laboratory Medicine (CCLM) 58(7): 1131-1134, 2020.

C. Sardu, J. Gambardella, M. B. Morelli, X. Wang, R. Marfella, and G. Santulli, “Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence,” Journal of Clinical Medicine 9(5): 1417, 2020.

C. Magro, J. J. Mulvey, D. Berlin, G. Nuovo, S. Salvatore, J. Harp, A. Baxter-Stoltzfus and J. Laurence, “Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases,” Translational Research 220, 1-13, 2020.

World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. Geneva: World Health Organization; 2020. 62 p. Report No.: WHO/2019-nCoV/clinical/2020.5

N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, Y. Qiu, J. Wang, Y. Liu, Y. Wei and T. Yu, “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study,” The Lancet 395(10223): 507-13, 2020.

D. Konukoglu “COVID-19: Clinical and pathophysiological features and laboratory diagnosis,” International Journal of Medical Biochemistry 3(2): 47-51, 2020.

A. J. Rodriguez-Morales, J. A. Cardona-Ospina, E. Gutiérrez-Ocampo, R. Villamizar-Peña, Y. Holguin-Rivera, J. P. Escalera-Antezana, L. E. Alvarado-Arnez, D. K. Bonilla-Aldana, C. Franco-Paredes, A. F. Henao-Martinez and A. Paniz-Mondolfi, “Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis,” Travel Medicine and Infectious Disease 34: 101623, 2020.

Q. Li, Y. Cao, L. Chen, D. Wu, J. Yu, H. Wang, W. He, L. Chen, F. Dong, W. Chen and W. Chen, “Hematological features of persons with COVID-19. Leukemia,” 34(8): 2163- 2172, 2020.

C. Wang, R. Deng, L. Gou, Z. Fu, X. Zhang, F. Shao, G. Wang, W. Fu, J. Xiao, X. Ding and T. Li, “Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters,” Annals of Translational Medicine 8(9): 1-15, 2020.

R. D. Jiang, M. Q. Liu, Y. Chen, C. Shan, Y. W. Zhou, X. R. Shen, Q. Li, L. Zhang, Y. Zhu, H. R. Si and Q. Wang, “Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2,” Cell 182(1): 50-58, 2020.

L. Tan, Q. Wang, D. Zhang, J. Ding, Q. Huang, Y. Q. Tang, Q. Wang and H. Miao, “Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study,” Signal Transduction and Targeted Therapy 5(1): 1-3, 2020.

W. J. Guan, Z. Y. Ni, Y. Hu, W. H. Liang,C. Q. Ou, J. X. He, L. Liu, H. Shan, C. L. Lei, D. S. Hui and B. Du, “Clinical characteristics of coronavirus disease 2019 in China,” New England Journal of Medicine 382(18): 1708-1720, 2020.

Q. Shi, K. L. Zhao, J. Yu, J. R. Feng, K. P. Zhao, X. Y. Zhang, X. Y. Chen, P. Hu, Y. P. Hong, M. Li and F. Liu, “Clinical characteristics of 101 non-surviving hospitalized patients with COVID-19—A single center, retrospective study,” MedRxiv 1-24, 2020.


Download data is not yet available.


How to Cite
Layla, K. N., Yeasmin, S., Khan, S. A., Shaila, K. N., Azad, A. B., Ahmad, R., & Rahman, S. (2021). White Blood Cell Profile among Different Clinical Stages of COVID-19 Patients . European Journal of Medical and Health Sciences, 3(5), 73–76. https://doi.org/10.24018/ejmed.2021.3.5.1051